Breakthrough in immunotherapy: Novartis receives first ever FDA approval for a CAR-T cell therapy fo
Novartis announced today that the US Food and Drug Administration (FDA) has approved Kymriah(TM) (tisagenlecleucel) suspension for...
top of page
Our Recent Posts
Archive
Tags
Blog: Blog
bottom of page